Inactivation of MAP kinase signalling in Myc transformed cells and rescue by LiCl inhibition of GSK3

Molecular Cancer

Volumn 4, Issue , 2005, Pages

  Al Assar, Osama ^a,b   Crouch, Dorothy H ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; LITHIUM CHLORIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL TRANSFORMATION; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; FIBROBLAST; MOLECULAR MECHANICS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; CELL LINE; CULTURE MEDIUM; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HALF LIFE TIME; METABOLISM; ONCOGENE MYC; PHOSPHORYLATION; PHYSIOLOGY; RETRACTED ARTICLE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CHICK EMBRYO; CULTURE MEDIA, SERUM-FREE; FIBROBLASTS; GENES, MYC; GLYCOGEN SYNTHASE KINASE 3; HALF-LIFE; LITHIUM CHLORIDE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; ONCOGENE PROTEIN P55(V-MYC); PHOSPHORYLATION;

EID: 26844570606     PISSN: 14764598     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-4-13     Document Type: Article

References (38)

1. Levens DL: Reconstructing MYC. Genes Dev 2003, 17:1071-1077.
2. Nesbit CE, Tersak JM, Prochownik EV: MYC oncogenes and human neoplastic disease. Oncogene 1999, 18:3004-3016.
3. Hunter T: Oncoprotein networks. Cell 1997, 88:333-346.
4. Bouchard C, Staller P, Eilers M: Control of cell proliferation by Myc. Trends Cell Biol 1998, 8:202-206.
5. Watson JD, Oster SK, Shago M, Khosravi F, Penn LZ: Identifying genes regulated in a Myc-dependent manner. J Biol Chem 2002, 277:36921-36930.
6. Menssen A, Hermeking H: Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc Natl Acad Sci U S A 2002, 99:6274-6279.
7. Blackwood EM, Eisenman RN: Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 1991, 251:1211-1217.
8. Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H: Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 1992, 359:423-426.
9. Prendergast GC, Lawe D, Ziff EB: Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 1991, 65:395-407.
10. Flinn EM, Busch CM, Wright AP: myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol Cell Biol 1998, 18:5961-5969.
11. Dang CV: c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 1999, 19:1-11.
12. Lutterbach B, Hann SR: Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol 1994, 14:5510-5522.
13. Lutterbach B, Hann SR: c-Myc transactivation domain-associated kinases: questionable role for map kinases in c-Myc phosphorylation. J Cell Biochem 1999, 72:483-491.
14. Hancock JF: Ras proteins: different signals from different locations. Nat Rev Mol Cell Biol 2003, 4:373-384.
15. Kimmelman AC, Osada M, Chan AM: R-Ras3, a brain-specific Rasrelated protein, activates Akt and promotes cell survival in PC12 cells. Oncogene 2000, 19:2014-2022.
16. Yan J, Roy S, Apolloni A, Lane A, Hancock JF: Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J Biol Chem 1998, 273:24052-24056.
17. Voice JK, Klemke RL, Le A, Jackson JH: Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J Biol Chem 1999, 274:17164-17170.
18. Self AJ, Caron E, Paterson HF, Hall A: Analysis of R-Ras signalling pathways. J Cell Sci 2001, 114:1357-1366.
19. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G: Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 1997, 385:544-548.
20. Lee HY, Srinivas H, Xia D, Lu Y, Superty R, LaPushin R, Gomez-Manzano C, Gal AM, Walsh GL, Force T, Ueki K, Mills GB, Kurie JM: Evidence That Phosphatidylinositol 3-Kinase- and Mitogenactivated Protein Kinase Kinase-4/c-Jun NH2-terminal Kinase-dependent Pathways Cooperate to Maintain Lung Cancer Cell Survival. J Biol Chem 2003, 278:23630-23638.
21. Chang L, Karin M: Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
22. Morgan MA, Dolp O, Reuter CW: Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling. Blood 2001, 97:1823-1834.
23. Zheng B, Fiumara P, Li YV, Georgakis G, Snell V, Younes M, Vauthey JN, Carbone A, Younes A: MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. Blood 2003, 102:1019-1027.
24. Fincham VJ, James M, Frame MC, Winder SJ: Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src. Embo J 2000, 19:2911-2923.
25. Treinies I, Paterson HF, Hooper S, Wilson R, Marshall CJ: Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis. Mol Cell Biol 1999, 19:321-329.
26. McCarthy SA, Samuels ML, Pritchard CA, Abraham JA, McMahon M: Rapid induction of heparin-binding epidermal growth factor/ diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev 1995, 9:1953-1964.
27. Clark W, Black EJ, MacLaren A, Kruse U, LaThangue N, Vogt PK, Gillespie DA: v-Jun overrides the mitogen dependence of Sphase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity. Mol Cell Biol 2000, 20:2529-2542.
28. Kim JW, Lee JE, Kim MJ, Cho EG, Cho SG, Choi EJ: Glycogen synthase kinase 3 beta is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1). J Biol Chem 2003, 278:13995-14001.
29. Hetman M, Hsuan SL, Habas A, Higgins MJ, Xia Z: ERK1/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neurons. J Biol Chem 2002, 277:49577-49584.
30. Petropoulos CJ, Givol I, Hughes SH: Comparative analysis of the structure and function of the chicken c-myc and v-myc genes: v-myc is a more potent inducer of cell proliferation and apoptosis than c-myc. Oncogene 1996, 12:2611-2621.
31. Lee CM, Reddy EP: The v-myc oncogene. Oncogene 1999, 18:2997-3003.
32. Bijur GN, De Sarno P, Jope RS: Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J Biol Chem 2000, 275:7583-7590.
33. Gopalbhai K, Meloche S: Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins. J Cell Physiol 1998, 174:35-47.
34. Black EJ, Walker M, Clark W, MacLaren A, Gillespie DA: Cell transformation by v-Jun deactivates ERK MAP kinase signalling. Oncogene 2002, 21:6540-6548.
35. Gregory MA, Qi Y, Hann SR: Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem 2003, 278:51606-51612.
36. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR: Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 2000, 14:2501-2514.
37. La Rocca SA, Crouch DH, Gillespie DA: c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation. Oncogene 1994, 9:3499-3508.
38. Gavine PR, Neil JC, Crouch DH: Protein stabilization: a common consequence of mutations in independently derived v-Myc alleles. Oncogene 1999, 18:7552-7558.